DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder ValueGlobeNewsWire • 09/16/24
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."GlobeNewsWire • 01/30/24
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four YearsGlobeNewsWire • 11/28/23
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder's Common StockGlobeNewsWire • 11/08/23
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing RuleGlobeNewsWire • 10/26/23
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact BiomedicalGlobeNewsWire • 10/23/23
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management SubsidiaryGlobeNewsWire • 09/06/23
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.GlobeNewsWire • 07/31/23
DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.GlobeNewsWire • 07/05/23
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.GlobeNewsWire • 06/30/23
DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special DividendGlobeNewsWire • 06/26/23
DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023GlobeNewsWire • 05/16/23
DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS ShareholdersGlobeNewsWire • 05/01/23
DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to ShareholdersGlobeNewsWire • 04/19/23
DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase LabsGlobeNewsWire • 07/21/22
DSS Strengthens and Expands Board with Appointment of Two Independent DirectorsGlobeNewsWire • 07/13/22